Weekly vs Bi-Weekly shots: new diabetes drugs face off in trial
NCT ID NCT07055386
Summary
This study is testing two new injectable medications (GZR102 given weekly and GZR18 given every two weeks) for adults with type 2 diabetes. It's for people whose current GLP-1 medication isn't controlling their blood sugar well enough, even if they're also taking diabetes pills. The main goal is to see which injection schedule works better at lowering long-term blood sugar levels (HbA1c) and is safer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site 01
Beijing, China
Conditions
Explore the condition pages connected to this study.